WASHINGTON (Reuters) - Myriad Genetics' disputed patent on the BRCA1 breast cancer gene is "surprisingly broad" and could interfere with future research, three experts said on Tuesday. Their ongoing research indicates some other gene patents are similarly extensive, covering stretches of DNA that have nothing to do with the targeted genes, they reported in the journal Genomics. "We find that, through ...

A simple genetic test can help pinpoint the precise dose of a potentially life-saving medication taken by millions to ward off blood clotting after heart surgery, a study published Tuesday found. The clinical study led by two leading medical researchers -- Medco Research Institute specializing in pharmacy care, and the Mayo Clinic in Rochester, Minnesota -- found that hospital stays can be ...

A simple genetic test can help pinpoint the precise dose of a potentially life-saving medication taken by millions to ward off blood clotting after heart surgery, a study published Tuesday found. The clinical study led by two leading medical researchers -- Medco Research Institute specializing in pharmacy care, and the Mayo Clinic in Rochester, Minnesota -- found that hospital stays can be ...

Doctors are reporting an exciting win for gene testing and personalized medicine: Checking patients' DNA before starting them on a popular blood thinner helps get the tricky dose right and keep them out of the hospital. The drug is warfarin, sold as Coumadin and in generic form. About 2 ...